Barlow maneuver
Barlow maneuver is a clinical test used in orthopedics to diagnose congenital hip dislocation (CHD) or developmental dysplasia of the hip (DDH) in infants. The test is named after the British orthopedic surgeon, Thomas Barlow, who developed the maneuver. It is commonly performed alongside the Ortolani maneuver as part of the newborn physical examination to detect hip instability or dislocation.
Procedure[edit]
The Barlow maneuver is performed with the infant in a supine position. The examiner holds the infant's knee and thigh in one hand while stabilizing the pelvis with the other hand. The thigh is then gently adducted (moved towards the midline of the body) while applying light posterior pressure on the knee, attempting to dislocate the hip posteriorly. A positive Barlow test is indicated if the hip can be felt to dislocate or subluxate under this pressure. The maneuver is then repeated on the opposite side.
Significance[edit]
A positive Barlow maneuver suggests that the infant's hip is unstable and may be dislocated or prone to dislocation. Early detection of DDH is crucial as it can lead to developmental problems with the hip joint, including limping, leg length discrepancy, and osteoarthritis in later life. If detected early, DDH can often be treated successfully with non-surgical methods such as the use of a Pavlik harness, which helps to keep the hip in the correct position as it develops.
Related Tests[edit]
The Ortolani maneuver is another test used to detect DDH. Unlike the Barlow maneuver, which tests for the possibility of dislocating a stable hip, the Ortolani maneuver checks for the ease of reducing a dislocated hip back into the socket. Both tests are essential for the early detection and treatment of DDH.
See Also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian